You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德琪醫藥(06996.HK)與德睿智藥達成小分子抗腫瘤首創新藥研發戰略合作
阿思達克 08-09 11:51
德琪醫藥(06996.HK)宣布,與AI藥物研發公司德睿智藥(MindRank AI)達成長期戰略合作,將共同推進小分子抗腫瘤首創新藥的研發,旨在提高當前藥物研發效率與成功率,為患者提供突破性的治療方案。 公司表示,目前德睿智藥已經對德琪醫藥一款臨床前候選藥物研發作出貢獻,德睿智藥將使用其特有的一站式AI藥物研發平檯球Molecule Pro和分子動力學平台Molecule Dance,輔助公司設計並獲得更多具有同類首款(FIC)及同類最優(BIC)候選藥物。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account